Results for tag: "Bococizumab"

Bococizumab is a monoclonal antibody used in the treatment of cardiovascular diseases. It is designed to reduce the risk of cardiovascular events, such as heart attack and stroke, in patients with atherosclerosis. Bococizumab works by targeting a protein called PCSK9, which is involved in the regulation of cholesterol levels in the body. By blocking PCSK9, bococizumab helps to reduce the amount of cholesterol in the blood, thus reducing the risk of cardiovascular events. Bococizumab is administered as an injection, and is typically used in combination with other medications, such as statins, to reduce cholesterol levels. It is approved for use in the United States, Europe, and other countries. The bococizumab market is highly competitive, with several companies offering similar products. Some of the major players in the market include Amgen, Sanofi, Regeneron, and Pfizer. Show Less Read more